State Access To Innovative Medicines Coalition

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 853070840 ✦ Washington, DC ✦ Designated as a 501(c)(4)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is State Access To Innovative Medicines Coalition?

The State Access to Innovative Medicines Coalition is a collaborative nonprofit organization based in Washington, D.C. It brings together patient advocacy groups, healthcare providers, and life sciences organizations to work on state policies that enhance patient access to innovative medicines. The coalition's strategy involves developing coordinated advocacy and lobbying tactics for its members to utilize in their respective state-level engagements. The primary objective is to improve patient access to cutting-edge medicines. The coalition's efforts are collaborative, with all its members contributing to the cause.


Official website here: www.saimcoalition.org

Is State Access To Innovative Medicines Coalition legitimate?

State Access To Innovative Medicines Coalition is a legitimate nonprofit organization registered as a 501(c)(4) entity. State Access To Innovative Medicines Coalition submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Official website here: www.saimcoalition.org

What is the mission statement of State Access To Innovative Medicines Coalition?

The State Access To Innovative Medicines Coalition aims to foster collaboration between patient advocacy groups, healthcare providers, and life sciences organizations. Their mission is to advance state policies that enhance patient access to innovative medicines. They achieve this by developing coordinated strategies for their members to utilize in their advocacy and lobbying activities at the state level. All members contribute to this collective effort, working towards the common goal of improving patient access to cutting-edge medications.


Official website here: www.saimcoalition.org

Who is the CEO of State Access To Innovative Medicines Coalition?

Unavailable


Official website here: www.saimcoalition.org

What is the revenue of State Access To Innovative Medicines Coalition?

State Access To Innovative Medicines Coalition's revenue in 2022 was $124,750.


Official website here: www.saimcoalition.org

Who are the executives of State Access To Innovative Medicines Coalition and what are their salaries?


Here are 5 key members and their salaries:


Brian Henderson--Secretary Chair (To Past Chair (Trans @ 7/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Michele Guadalupe (Chair-Elect To Chair (Trans @ 7/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Catherine Peters (Treas To Chair-Elect (Trans @ 7/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Steven Schultz (Treasurer (7/22-9/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Lucy Culp (Secretary (7/22-12/22))
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.saimcoalition.org

Where can I find the form 990EZ for State Access To Innovative Medicines Coalition?

State Access To Innovative Medicines Coalition's most recent form 990EZ was submitted in 2022 and can be accessed here.


Official website here: www.saimcoalition.org

Learn more at the official website: www.saimcoalition.org

Mission Statement of State Access To Innovative Medicines Coalition

The State Access to Innovative Medicines Coalition is a collaborative entity that brings together patient advocacy groups, healthcare providers, and life sciences organizations. Its mission, in simple terms, is to foster cooperation among these entities to advance state policies that enhance patient access to groundbreaking medicines. The coalition achieves this by devising coordinated strategies for its members to employ in their state-level advocacy and lobbying activities. Each member contributes to this collective effort, working towards the common goal of improving patient access to innovative medicines. By doing so, the State Access to Innovative Medicines Coalition plays a vital role in facilitating collaborative efforts that aim to benefit patients, ultimately contributing to advancements in healthcare and medicine.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The State Access To Innovative Medicines Coalition plays a significant role in enhancing patient access to innovative medications by fostering collaboration among various stakeholders, including patient advocacy groups, healthcare providers, and life sciences organizations. By aligning these diverse entities, the coalition effectively champions state-level policies that prioritize and improve access to new treatments.

Its structured advocacy and lobbying strategy empowers members to engage collectively in state-level initiatives, ensuring that their voices are heard in policymaking discussions. This coordinated approach not only amplifies the collective impact of its members but also streamlines efforts to navigate the complexities of healthcare legislation. Through this collaboration, the coalition aims to address barriers that patients face in obtaining innovative medicines, ultimately striving to improve health outcomes across communities.

Located in Washington, DC, the coalition’s efforts are crucial in a landscape where state policies can significantly influence healthcare access. By mobilizing resources and expertise from various sectors, the State Access To Innovative Medicines Coalition effectively advocates for changes that benefit patients and keeps the dialogue around access to innovative treatments at the forefront of health policy discussions.




This information is meant to be a general summary of State Access To Innovative Medicines Coalition. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$124,750 (2022)
Expenses
$178,593 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Gross Receipts: $124,750

Assets and Liabilities:

  • Total Assets: $176,169
  • Total Liabilities: $0
  • Net Assets: $176,169

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Main Address

1500 K ST NW 1100, WASHINGTON, DC, 20005

NTEE Category

Code: E01 - Health

If you are a representative of State Access To Innovative Medicines Coalition and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.